Cargando…
非小细胞肺癌免疫治疗生物标志物的研究进展
Lung cancer is a malignant tumor with the highest mortality in the world. The most common pathological type of lung cancer is non-small cell lung cancer (NSCLC). In recent years, immunotherapy has brought about epoch-making changes in the treatment of NSCLC. In particular, immune checkpoint inhibito...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607290/ https://www.ncbi.nlm.nih.gov/pubmed/34802209 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.40 |